Eco R1 Capital, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Eco R1 Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $5.22 Million - $9.02 Million	300,000 New	300,000 $8.46 Million
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $2.06 Million - $6.02 Million	-115,236 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$41.58 - $80.89 $4.79 Million - $9.32 Million	115,236 New	115,236 $5.32 Million
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $9.37 Million - $14.7 Million	-200,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $7.48 Million - $12.5 Million	200,000 New	200,000 $10.6 Million

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $171M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Eco R1 Capital, LLC with notifications on news.